NGEN NervGen Pharma Corp.
$1.73▼ -4.42%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$183.73M
P/E Ratio
–
Div Yield
–%
52W Range
1.70 - 6.30
% vs 50 MA
-47.42%
% vs 200 MA
-50.01%
RSI-14
23.3
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.63
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
N/A
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Avg +0.75 · 4 posts
NewsDiscussionTradePublic offering of stock: NervGen Pharmaceuticals: $ngen and what should current holders do about it?
r/stocks · May 22, 2026
The post focuses on a public offering and asks about holding strategies, indicating potential positive sentiment regarding the company.
positive
+0.60
Thoughts on Nerven Pharma ($NGEN) ?
r/stocks · Jan 19, 2026
The comments highlight promising trial results and significant stock performance, indicating a bullish sentiment.
positive
+0.80
NewsDD$NGEN - Experimental Drug Shows Results
r/wallstreetbets · Oct 3, 2025
The user reports regaining full arm function and significant improvements, indicating extremely positive results for the company.
very_positive
+1.00
DDNewsTradeNGEN up 120% in the last month, trial results on June 3rd, don't sleep on this one
r/wallstreetbets · May 21, 2025
The post highlights a significant price increase and encourages investment, suggesting a positive sentiment toward the stock.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.